Critical care health care professionals have one of the highest rates of burnout syndrome (BOS), compared to other health care professionals, according to a call-to-action statement published in the American Journal of Respiratory and Critical Care Medicine.
The Food and Drug Administration (FDA) has granted Orphan Drug designation for mazindol (NLS Pharma) for the treatment of narcolepsy.
For patients with Chronic Obstructive Pulmonary Disease (COPD) and a co-morbidity of depression, adherence to COPD maintenance medication is particularly low.
Data from the first randomized clinical trial evaluating the efficacy of antidepressants with or without complicated grief psychotherapy for the treatment of complicated grief showed that adding citalopram to complicated grief treatment (CGT) helped treat concurrent depressive symptoms.
Combining psychotherapeutic and psychopharmacological interventions is likely to be more efficacious than psychotherapeutic interventions alone for the management of obsessive-compulsive disorder (OCD), a study published in Lancet Psychiatry has shown.
The U.S. Preventive Services Task Force (USPSTF) has found insufficient evidence for the benefit of obstructive sleep apnea (OSA) screening in asymptomatic populations.
Acadia announced the launch of Nuplazid (pimavanserin) tablets for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis.
In the most definitive study to date, cigarette smoking during pregnancy was linked to a greater likelihood of schizophrenia in offspring. Those are the findings of a new long-term study which assessed maternal nicotine exposure (via cotinine levels) during pregnancy.
Patients taking antipsychotic agents may be at an increased risk of myocardial infarction, based on a review of nine observational studies.
Repeated doses of intravenous (IV) ketamine quickly reduced suicidal ideation in pharmacologically treated outpatients with treatment-resistant depression with stable suicidal thoughts, according to a study published in the Journal of Clinical Psychiatry.
A Vital Signs report from the Centers for Disease Control and Prevention (CDC) found that among insured children 2-5 years old receiving care for attention deficit hyperactivity disorder (ADHD), medication treatment was more common than the recommended first-line treatment of psychological services.
Mindfulness-based cognitive therapy may help reduce the risk of repeated episodes of depression, according to a study published online in JAMA Psychiatry.
Older men who receive androgen deprivation therapy (ADT) for prostate cancer may be at increased risk of developing depression, according to a new.
Takeda and Lundbeck announced that the FDA has issued a complete response letter for the sNDA regarding the addition of new clinical trial data to the Brintellix (vortioxetine) labeling for treating certain aspects of cognitive dysfunction in adults with major depressive disorder (MDD).
Forum Pharmaceuticals announced topline results from two Phase 3 clinical trials evaluating encenicline (FRM-6124) in patients with cognitive impairment in schizophrenia (CIS).
Adolescents and young adults with autism spectrum disorder (ASD) are more likely to develop type 2 diabetes mellitus (T2DM), according to a study published online in Diabetes Care.
U.S. primary care practices use less than one care management process for depression, on average, according to a study published in the March issue of Health Affairs.
Alkermes announced positive top-line results from its pharmacokinetics trial of Aristada (aripiprazole lauroxil extended-release injectable suspension).
Auricular acupressure is an effective alternative complementary therapy for postpartum women with insomnia, according to a study published in the issue of the Journal of Clinical Nursing.
Childhood attention-deficit/hyperactivity disorder (ADHD) is associated with increased obesity in females, according to a study published online in the Mayo Clinic Proceedings.
Therapist-guided, Internet-based cognitive behavioral therapy (CBT) for body dysmorphic disorder (BDD-NET) is superior to online supportive therapy, according to a study published online February 2 in The BMJ.